GL1X · GenesisL1 explorer

UniProt C6KTA4

Pyruvate kinase (C6KTA4)

Pyruvate kinase (UniProt C6KTA4), EC 2.7.1.40: 12 experimental structures on GenesisL1, 5 ligands bound, 70 pockets. Binding sites, pockets, druggability and 3D structures in GL1X.

UniProt
C6KTA4
Protein
Pyruvate kinase
EC
2.7.1.40
Experimental structures
12
Predicted models
0
Ligands
5
Pockets
70 · 8 records with a druggable one

Structures

12 records of C6KTA4 in the MolNFT archive: 12 experimental, 0 predicted.

EntryTitleMethodChainsLigandsPockets
3KHDCrystal Structure of PFF1300w.x-ray diffractionA, B, C, D——
3KHDCrystal structure of PFF1300W.x-ray diffractionA, B, C, D——
6KSHCrystal structure of pyruvate kinase (PYK) from Plasmodium falciparum in complex with oxalate and…x-ray diffractionA, B, C, DMG, ATP, K, OXL20 (best 0.85)
6KSHCrystal structure of pyruvate kinase (pyk) from plasmodium falciparum in complex with oxalate and…x-ray diffractionA, B, C, DMG, ATP, K, OXL—
7Z4MPlasmodium falciparum pyruvate kinase complexed with Mg2+ and K+x-ray diffractionAMG, K9 (best 0.66)
7Z4MPlasmodium falciparum pyruvate kinase complexed with MG2+ and K+x-ray diffractionAMG, K9 (best 0.66)
7Z4NPlasmodium falciparum pyruvate kinase complexed with pyruvatex-ray diffractionAMG, K, PYR5 (best 0.73)
7Z4NPlasmodium falciparum pyruvate kinase complexed with pyruvatex-ray diffractionAMG, K, PYR5 (best 0.73)
7Z4QPlasmodium falciparum pyruvate kinase mutant - C49Ax-ray diffractionAMG8 (best 0.63)
7Z4QPlasmodium falciparum pyruvate kinase mutant - C49A———
7Z4RPlasmodium falciparum pyruvate kinase mutant - C343Ax-ray diffractionAMG, K7 (best 0.67)
7Z4RPlasmodium falciparum pyruvate kinase mutant - C343Ax-ray diffractionAMG, K7 (best 0.67)

Ligands

  • MG · Magnesium ion · in 9 records
  • K · Potassium ion · in 8 records
  • ATP · Adenosine-5'-triphosphate · in 2 records
  • OXL · Oxalate ion · in 2 records
  • PYR · Pyruvic acid · in 2 records

Elsewhere

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.